Cardiology

Pulmonary Artery Banding in India and UAE | Complete Patient Guide

Q: What is the cost of Pulmonary Artery Banding in India compared to the UAE?

The all-inclusive cost of Pulmonary Artery Banding in India ranges from approximately USD 4,000 to USD 8,000, covering surgery, anaesthesia, Paediatric Cardiac ICU stay, general ward stay, standard postoperative medications, and routine follow-up echocardiograms before discharge. In the UAE (Dubai or Abu Dhabi), the equivalent package costs approximately USD 12,000 to USD 22,000 at JCI-accredited, DHA/DOH-licensed private hospitals such as Cleveland Clinic Abu Dhabi or Mediclinic City Hospital. India therefore offers a cost saving of approximately 50–65% compared to the UAE, while delivering outcomes from NABH- and JCI-accredited, high-volume paediatric cardiac centres that perform hundreds of congenital heart surgeries annually. The final cost in either destination depends on the specific complexity of the infant's cardiac anatomy, the duration of ICU stay required, whether an adjustable banding device (such as the FloWatch® system) is used, and any additional interventions needed. GAF Healthcare provides a fully itemised, transparent cost estimate before any commitment is made.

Q: How long does my child need to stay in the country before being fit to fly home after Pulmonary Artery Banding?

Families should plan for a total stay of 3 to 6 weeks in the destination country following Pulmonary Artery Banding. The hospital stay itself typically spans 7 to 14 days, of which 2 to 4 days are in the Paediatric Cardiac ICU followed by step-down to the general paediatric ward. After hospital discharge, a mandatory post-discharge outpatient monitoring period of 2 to 4 additional weeks is required before the cardiologist can issue a fitness-to-fly certificate. Criteria that must be met before international air travel include: haemodynamically stable band position confirmed on repeat echocardiogram, oxygen saturations at the target range for the specific cardiac diagnosis (typically 75–85% for cyanotic lesions), absence of pleural effusion or wound complications, the infant feeding adequately with acceptable weight gain, and stable oral medication regimen that the family can manage independently. Commercial air travel at cabin pressure altitude equivalent (approximately 8,000 feet / 2,400 metres) poses additional haemodynamic stress; for some infants with marginal saturations, supplemental in-flight oxygen may be prescribed. GAF Healthcare coordinates the outpatient review appointments and works directly with the cardiac team to ensure all clearance criteria are documented before the family departs.

Q: What is the success rate of Pulmonary Artery Banding?

Pulmonary Artery Banding has a procedural success rate of 90–95% at high-volume paediatric cardiac centres in India and the UAE, where 'procedural success' is defined as achieving the target haemodynamic goals — a distal pulmonary artery pressure of 25–35% of systemic pressure and the target oxygen saturation range — without major intraoperative complications. In-hospital mortality for isolated PAB in a haemodynamically stable infant is reported at 1–3% at experienced centres, rising to 5–15% in critically ill neonates or those with severe associated comorbidities. Long-term survival to planned corrective cardiac surgery (the ultimate goal of PAB) exceeds 80% in contemporary series from centres using modern surgical techniques, intraoperative epicardial echocardiography guidance, and dedicated Paediatric Cardiac ICU postoperative care. It is important to understand that PAB is a palliative bridge procedure, not a cure; the long-term cardiac outcome depends on the complexity of the underlying congenital heart defect and the success of the definitive corrective operation planned for a later stage. GAF Healthcare connects families exclusively to hospitals with documented, audited congenital heart surgery outcomes, ensuring the highest probability of a successful result.

Pulmonary Artery Banding (PAB) is a precise palliative cardiac surgical procedure performed in neonates and infants with complex congenital heart defects — including large ventricular septal defects (VSD), double-inlet left ventricle, and hypoplastic left heart syndrome — to reduce excessive pulmonary blood flow, prevent irreversible pulmonary hypertension, and stabilise the child before a definitive corrective operation. Centres of excellence in India and the UAE report procedural success rates exceeding 90–95% in carefully selected patients, with outcomes benchmarked against leading international paediatric cardiac programmes. GAF Healthcare connects international families to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centres in Dubai and Abu Dhabi, providing end-to-end medical travel coordination so that parents can focus entirely on their child's recovery.

Hospital Stay

7–10 days

Success Rate

90%

Available in

India

Pulmonary Artery Banding in India

Get Pulmonary Artery Banding at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.

Pulmonary Artery Banding in UAE

Pulmonary Artery Banding at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.

Overview

Hospital Stay: 7–14 days (includes 2–4 days in Paediatric Cardiac Intensive Care Unit followed by general ward observation) • Total Stay in Country (Fit-to-Fly): 3–6 weeks from the date of surgery (cardiologist clearance, repeat echocardiogram, and stable oxygen saturation required before international air travel) • Success Rate: 90–95% procedural success; long-term survival to planned corrective surgery exceeds 80% in high-volume centres

What Is It?

Pulmonary Artery Banding is a palliative surgical technique in which a calibrated constricting band — typically fashioned from Gore-Tex, silicone-reinforced Teflon tape, or a flow-restrictor device — is placed around the main pulmonary artery (MPA) to deliberately narrow its lumen and reduce left-to-right shunting of oxygenated blood into the pulmonary circulation. In congenital heart defects characterised by unrestricted pulmonary blood flow (Qp:Qs ratio often exceeding 2:1), the pulmonary vasculature is exposed to excessive pressure and volume, driving pathological vascular remodelling characterised by medial hypertrophy, intimal proliferation, and, ultimately, irreversible pulmonary arterial hypertension (Heath-Edwards Grade III–VI). PAB interrupts this cascade by targeting a post-banding distal pulmonary artery pressure of approximately 25–35% of systemic pressure and an oxygen saturation of 75–85% in cyanotic lesions, thereby protecting the pulmonary vascular bed and allowing the infant to grow to a weight and haemodynamic status suitable for complete intracardiac repair.

From a physiological standpoint, correct band calibration is the most critical determinant of outcome. An over-tight band generates right ventricular pressure overload, tricuspid regurgitation, and ventricular failure, while an under-tight band fails to protect the pulmonary vasculature. Intraoperative assessment relies on direct pulmonary artery pressure measurement via needle manometry, pulse oximetry trending, and — increasingly — real-time epicardial echocardiography to evaluate ventricular function and septal position dynamically. The Trusler formula (circumference in mm = 20 + weight in kg for simple VSD; 24 + weight in kg for complex lesions) provides a starting reference, but experienced paediatric cardiac surgeons individualize band tightness based on haemodynamic response.

The standard of care at high-volume Indian and UAE paediatric cardiac centres integrates preoperative cardiac catheterisation or high-resolution cardiac CT angiography (256-slice or dual-source), advanced anaesthetic neonatal protocols including low-flow cardiopulmonary bypass or off-pump approaches for isolated banding, and postoperative management in dedicated Paediatric Cardiac ICUs staffed by 24/7 paediatric cardiac intensivists. Emerging adjunctive technologies include the FloWatch® and similar adjustable PAB devices, which allow percutaneous transcatheter adjustment of band tension post-implantation without reoperation — a capability now available at select tertiary centres in both India and the UAE.

Candidates

• ELIGIBLE DIAGNOSES: Large unrestrictive ventricular septal defect (VSD) with pulmonary-to-systemic flow ratio (Qp:Qs) > 2:1; Double-outlet right ventricle (DORV); Complete atrioventricular septal defect (AVSD) in patients with Down syndrome or other contraindications to early complete repair; Hypoplastic left heart syndrome (HLHS) as part of a hybrid Norwood Stage I strategy; Single-ventricle anatomy (double-inlet left ventricle, tricuspid atresia with transposition) prior to bidirectional Glenn procedure; Aortopulmonary window with complex anatomy; Corrected transposition of the great arteries (cc-TGA) with VSD where pulmonary artery banding serves as left ventricular retraining prior to anatomic arterial switch.

• WEIGHT AND AGE PARAMETERS: Most candidates are neonates to infants under 6 months of age or weighing less than 5–6 kg, where primary complete repair carries prohibitive risk; PAB may also be considered in older infants with severe comorbidities (prematurity, lung disease, necrotising enterocolitis sequelae, severe malnutrition).

• REQUIRED PREOPERATIVE DIAGNOSTICS: Transthoracic echocardiography (TTE) with full segmental analysis and colour-flow Doppler — mandatory; Cardiac catheterisation with pulmonary vascular resistance (PVR) calculation when pulmonary hypertension is suspected (PVR > 3 Wood units/m²); High-resolution cardiac CT angiography (CTA) for complex anatomy delineation of MPA, branch pulmonary arteries, and great vessel relationships; Chest X-ray (cardiothoracic ratio, pulmonary plethora grading); Full blood count, coagulation profile (PT, aPTT, fibrinogen), renal and hepatic function panel, blood group and crossmatch; Genetic karyotype (especially in AVSD/Down syndrome population); Preoperative respiratory assessment and optimisation (treat active respiratory infection prior to scheduling).

• CONTRAINDICATIONS: Established irreversible pulmonary arterial hypertension (PVR > 8–10 Wood units/m² unresponsive to vasodilator challenge — Eisenmenger physiology); Anatomy clearly amenable to safe primary complete repair at experienced centre; Active systemic sepsis or uncontrolled coagulopathy; Extremely low birth weight (< 1.5 kg) — relative contraindication requiring individualised multidisciplinary decision.

Procedure

STANDARD OPEN SURGICAL PAB (PRIMARY APPROACH) Performed via left lateral thoracotomy (most common) or median sternotomy (preferred when simultaneous procedures are planned), the main pulmonary artery is dissected free from the aorta and right pulmonary artery, and a measured band is passed around the MPA proximal to its bifurcation. The procedure is typically performed off cardiopulmonary bypass (off-pump), making it less physiologically stressful than full open-heart repair. Band material options include: (1) PTFE (Gore-Tex) strips — most widely used, inert, reliable; (2) Umbilical tape with silicone sheathing — cost-effective in resource-limited settings; (3) Polyester (Dacron) tape. Intraoperative epicardial echocardiography is now standard in high-volume centres to dynamically guide band tightness. Sutures anchoring the band to the MPA adventitia prevent migration.

HYBRID STAGE I PAB (ADVANCED — FOR HLHS AND SINGLE VENTRICLE) In the hybrid Norwood approach for hypoplastic left heart syndrome, bilateral PAB is combined with ductal stenting via cardiac catheterisation in the same session, avoiding the need for deep hypothermic circulatory arrest in a critically ill neonate. This approach has gained significant adoption at specialised centres in India (e.g., Narayana Health, Amrita Institute) and the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai). The catheter-based component uses balloon-expandable stents (typically 4–6 mm) deployed in the arterial duct under fluoroscopic guidance in the hybrid OR.

ADJUSTABLE PAB DEVICES The FloWatch® PAB system (EndoArt SA) and similar devices feature a subcutaneously implanted electromagnetic actuator connected to the band, enabling non-invasive percutaneous tightening or loosening of the band using an external handheld controller — eliminating the need for a second thoracotomy for band adjustment. Available at select high-volume centres in both India and the UAE, this technology is particularly valuable in patients with dynamic haemodynamic requirements or those awaiting significant weight gain before corrective surgery.

VIDEO-ASSISTED THORACOSCOPIC PAB (VATS-PAB) Minimally invasive thoracoscopic pulmonary artery banding — using 3–5 mm ports in neonates — is performed at a small number of pioneering paediatric cardiac centres. Advantages include reduced chest wall trauma, shorter ICU stay, and improved cosmesis. Requires specialised neonatal endoscopic instrumentation and an experienced minimally invasive paediatric cardiac team. Currently available at select centres in India.

POSTOPERATIVE BAND ADJUSTMENT VIA CARDIAC CATHETERISATION In cases where band under-tightening occurs postoperatively, interventional balloon dilation of the band is not standard; however, surgical re-exploration for band adjustment (tightening via suture plication or band replacement) is performed under general anaesthesia via the original thoracotomy incision if haemodynamic targets are not met at 24–48 hours.

Cost of Pulmonary Artery Banding: India vs. UAE

The cost of Pulmonary Artery Banding varies significantly depending on the destination, hospital tier, complexity of the underlying cardiac anatomy, and length of ICU stay required. India offers substantially lower costs — typically 50–65% less than the UAE — while maintaining internationally accredited, high-volume paediatric cardiac programmes. The UAE offers premium private hospital environments with multilingual care teams and easy accessibility for families from the GCC, Europe, and Africa. Both destinations include hospitals with JCI accreditation; leading Indian centres also hold NABH accreditation, while UAE hospitals operate under DHA (Dubai) or DOH (Abu Dhabi) licensure. The estimates below reflect all-inclusive packages covering surgery, anaesthesia, ICU stay, ward stay, standard postoperative medications, and routine post-discharge outpatient reviews.

Destination	Estimated Cost (USD)	Key Advantage
India	$4,000 – $8,000	~65% less than the UAE
UAE (Dubai/Abu Dhabi)	$12,000 – $22,000	Premium care, JCI/DHA accredited

Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.

Recovery & Aftercare

PHASE 1 — PRE-ARRIVAL CONSULTATION (2–4 weeks before travel) GAF Healthcare coordinates a telemedicine consultation between the family and the designated paediatric cardiac surgeon. All prior echocardiogram reports, cardiac catheterisation data, genetic results, and clinical summaries are reviewed. The surgical team confirms the diagnosis, proposes the operative strategy, and issues a formal treatment plan with itemised cost estimate. Visa invitation letters and medical documentation are prepared simultaneously.

PHASE 2 — ARRIVAL AND PREOPERATIVE WORKUP (Days 1–3) On arrival, the infant undergoes repeat transthoracic echocardiography at the hospital to confirm anatomy and current haemodynamics. Repeat blood work, chest X-ray, and anaesthetic assessment are completed. A paediatric cardiac anaesthesiologist meets the family to explain the anaesthetic plan and obtain informed consent. The infant is admitted to the paediatric cardiology ward for optimisation: nutritional support (nasogastric feeding if required), diuretics (furosemide, spironolactone) to reduce pulmonary oedema, and prophylactic antibiotics commenced 1 hour before incision.

PHASE 3 — SURGERY (Day 3–5 typically) The procedure takes approximately 1.5–3 hours under general endotracheal anaesthesia with continuous invasive arterial pressure monitoring, near-infrared spectroscopy (NIRS) cerebral oximetry, and intraoperative epicardial echocardiography. The surgeon places the calibrated band, confirms target haemodynamics, and closes the chest. The infant is transferred to the Paediatric Cardiac ICU (PCICU) intubated.

PHASE 4 — PCICU RECOVERY (Days 1–4 post-op) Ventilator weaning begins within 4–12 hours if haemodynamics are stable. Vasoactive support (dopamine, milrinone) is titrated and weaned. Pulmonary artery pressures are monitored via a temporary pulmonary artery line in selected cases. Repeat bedside echocardiography at 24 hours confirms band position and ventricular function. Oral feeding is reintroduced cautiously.

PHASE 5 — GENERAL WARD (Days 5–14) The infant is stepped down to the paediatric cardiac ward. Medications are transitioned to oral regimen: furosemide, spironolactone, captopril (for afterload reduction in left-to-right shunt lesions), and aspirin where indicated. Wound care, nutritional optimisation, and weight monitoring are ongoing. Discharge planning begins at Day 10–12 if the infant is feeding well, saturations are at target, and wound is clean.

PHASE 6 — POST-DISCHARGE OUTPATIENT PERIOD IN DESTINATION COUNTRY (Weeks 2–6) The family stays in GAF Healthcare-arranged accommodation near the hospital. Outpatient review at Day 7 post-discharge (approximately Day 21 overall) includes clinical assessment, repeat echocardiogram, and oxygen saturation measurement. A second review at Week 4–6 confirms stability for international air travel. The cardiologist issues a medical fitness-to-fly certificate with a detailed discharge summary, operative report, echocardiographic images, and medication schedule for the home country physician.

PHASE 7 — LONG-TERM FOLLOW-UP PAB is a palliative procedure; definitive corrective surgery (VSD closure, Fontan completion, arterial switch, or other) is planned at 6–18 months of age or when the child reaches 8–15 kg, depending on the underlying diagnosis. GAF Healthcare facilitates ongoing telemedicine follow-up and coordinates the corrective surgery admission when the time comes.

Risks & Considerations

Pulmonary Artery Banding, while considerably less physiologically demanding than complete open-heart repair, carries procedure-specific risks that must be honestly understood by families. Intraoperative risks include haemorrhage from pulmonary artery laceration during dissection (risk < 1% at high-volume centres), acute right ventricular failure from over-tightening of the band, and hypoxic episodes from under-tightening. Postoperative risks include band migration distally onto the pulmonary valve or into a branch pulmonary artery, causing progressive pulmonary valve regurgitation or unilateral branch PA stenosis; this complication occurs in approximately 5–10% of cases and may require early reoperation or catheter-based intervention. Pulmonary artery distortion at the band site — leading to challenging anatomy at subsequent corrective surgery — is a recognised limitation, particularly with prolonged banding intervals. Branch pulmonary artery stenosis (most commonly left PA, which is anatomically more susceptible) occurs in 10–20% and may require balloon dilation or surgical arterioplasty at the time of repair. General postoperative risks include surgical wound infection, chylothorax from thoracic duct injury (incidence ~2–3%), phrenic nerve injury (causing diaphragmatic palsy), and arrhythmias. Mortality risk for isolated PAB in a haemodynamically stable infant at a high-volume centre is reported at 1–3%; this rises to 5–15% in critically ill neonates with severe cardiac failure, low birth weight, or associated genetic syndromes. Families should also understand that PAB is not curative — it is a bridge to corrective surgery, and the long-term prognosis is ultimately determined by the complexity of the underlying cardiac anatomy and the success of the planned definitive operation.

Families should plan for a total stay of 3 to 6 weeks in the destination country following Pulmonary Artery Banding. The hospital stay itself typically spans 7 to 14 days, of which 2 to 4 days are in the Paediatric Cardiac ICU followed by step-down to the general paediatric ward. After hospital discharge, a mandatory post-discharge outpatient monitoring period of 2 to 4 additional weeks is required before the cardiologist can issue a fitness-to-fly certificate. Criteria that must be met before international air travel include: haemodynamically stable band position confirmed on repeat echocardiogram, oxygen saturations at the target range for the specific cardiac diagnosis (typically 75–85% for cyanotic lesions), absence of pleural effusion or wound complications, the infant feeding adequately with acceptable weight gain, and stable oral medication regimen that the family can manage independently. Commercial air travel at cabin pressure altitude equivalent (approximately 8,000 feet / 2,400 metres) poses additional haemodynamic stress; for some infants with marginal saturations, supplemental in-flight oxygen may be prescribed. GAF Healthcare coordinates the outpatient review appointments and works directly with the cardiac team to ensure all clearance criteria are documented before the family departs.

Pulmonary Artery Banding has a procedural success rate of 90–95% at high-volume paediatric cardiac centres in India and the UAE, where 'procedural success' is defined as achieving the target haemodynamic goals — a distal pulmonary artery pressure of 25–35% of systemic pressure and the target oxygen saturation range — without major intraoperative complications. In-hospital mortality for isolated PAB in a haemodynamically stable infant is reported at 1–3% at experienced centres, rising to 5–15% in critically ill neonates or those with severe associated comorbidities. Long-term survival to planned corrective cardiac surgery (the ultimate goal of PAB) exceeds 80% in contemporary series from centres using modern surgical techniques, intraoperative epicardial echocardiography guidance, and dedicated Paediatric Cardiac ICU postoperative care. It is important to understand that PAB is a palliative bridge procedure, not a cure; the long-term cardiac outcome depends on the complexity of the underlying congenital heart defect and the success of the definitive corrective operation planned for a later stage. GAF Healthcare connects families exclusively to hospitals with documented, audited congenital heart surgery outcomes, ensuring the highest probability of a successful result.

Why Plan Your Treatment Through Gaf Healthcare?

GAF Healthcare provides a structured, family-centred medical travel service covering every non-clinical dimension of the journey.

INDIA LOGISTICS:

• e-Medical Visa: GAF Healthcare prepares and submits the e-Medical Visa application for India on behalf of the patient (infant) and up to two accompanying attendants. India's e-Medical Visa permits a stay of 60 days per visit with up to three extensions, covering the full PAB recovery and outpatient monitoring period. Processing time is typically 3–5 business days.

• Hospital Coordination: We have established relationships with NABH- and JCI-accredited paediatric cardiac centres including Narayana Health (Kolkata, Bengaluru), AIIMS New Delhi, Amrita Institute of Medical Sciences (Kochi), Fortis Escorts Heart Institute (New Delhi), and Apollo Hospitals Chennai. We coordinate directly with the paediatric cardiac surgery department for priority scheduling.

• Accommodation: GAF Healthcare arranges fully serviced apartments or hospital-affiliated guest houses within 500 metres of the treating hospital, with 24-hour security, cooking facilities, and daily housekeeping — essential for families on 4–6 week stays.

• Airport Transfers: Private ambulance-equipped transfers from the airport to the hospital are arranged for the infant's safety; return transfers post-discharge use air-conditioned private vehicles.

• Translators: Dedicated Arabic, Russian, French, Swahili, and other language medical interpreters are available for ICU family meetings, surgical consent discussions, and discharge counselling.

UAE LOGISTICS:

• Visa Access: Citizens of over 50 countries receive visa-on-arrival or visa-free access to the UAE. For nationalities requiring advance visas, GAF Healthcare coordinates medical visa invitation letters from the treating hospital in Dubai or Abu Dhabi. UAE medical visas are typically processed within 5–7 business days.

• Hospital Coordination: GAF Healthcare works with JCI-accredited, DHA/DOH-licensed centres including Cleveland Clinic Abu Dhabi, Mediclinic City Hospital (Dubai), King's College Hospital Dubai, and American Hospital Dubai — all operating paediatric cardiac programmes with internationally trained surgeons.

• Accommodation: Serviced apartments and hotel partnerships near Dubai Healthcare City and Abu Dhabi's healthcare district are arranged at negotiated rates for attendant families.

• Airport Transfers: Private vehicle transfers with child safety seats and — where clinically indicated — medical escort are coordinated from Dubai International (DXB), Abu Dhabi International (AUH), or Al Maktoum International airports.

• Currency and Payments: GAF Healthcare provides transparent, upfront cost estimates in USD and facilitates wire transfer, card payments, or TPA/insurance coordination for eligible patients.

• Post-Discharge Support: A dedicated GAF case manager is reachable 24/7 via WhatsApp and phone throughout the family's stay in either country, ensuring immediate escalation if any clinical concern arises.

Patients Also Explore

Other treatments commonly sought by patients considering Pulmonary Artery Banding.

Breast Cancer Treatment

Cancer Care

Lung Cancer Treatment

Cancer Care

Brain Tumor Surgery

Neurology

Deep Brain Stimulation

Neurology

The arterial switch operation (TGA repair) in India costs USD 5,500–9,000 with a 94–97% survival rate. Complete guide covering the procedure, best hospitals, recovery timeline, and how GAF Healthcare coordinates surgery from abroad.

Read Guide